Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
Toni Celià-Terrassa(Princeton University), Timothy M. Thomson(Universidad Peruana Cayetano Heredia), Brian Ell(Princeton University), Jordi Milá(Hospital Clínic de Barcelona), Anna Arnal Estape(Institute for Research in Biomedicine), Juan José Lozano(Instituto de Salud Carlos III), Alexia Martínez de Paz(Cornell University), Marta Guerra‐Rebollo(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Óscar Meca‐Cortés(Institut de Biologia Molecular de Barcelona), Catalina Ulloa(Institut de Biologia Molecular de Barcelona), Yibin Kang(Rutgers, The State University of New Jersey), Jerónimo Blanco(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Pedro L. Fernández, Daniel Álvarez-Simón(Institut de Biologia Molecular de Barcelona), Roger R. Gomis(Institució Catalana de Recerca i Estudis Avançats), Francesca Mateo(Institut d'Investigació Biomédica de Bellvitge), Núria Rubio(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Rosanna Paciucci(Vall d'Hebron Institut de Recerca), Alba Díaz(Hospital Clínic de Barcelona), Raquel Bermudo(Hospital Clínic de Barcelona), Marian A. Martínez‐Balbás(Institut de Biologia Molecular de Barcelona), Antonio Garcı́a de Herreros(Universitat Pompeu Fabra), R. Vilella(Hospital Clínic de Barcelona), Conchi Estarás(Temple University)
Cited by 462
Related Papers
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
|Genome Research|2016|278
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
|Proceedings of the National Academy of Sciences|1984|273